Ocuphire Pharma Results
AAO-Preferred Practice Pattern Reveals High Unmet Need in Mild, Moderate, and
Severe NPDR Patients
Unmet Need Remains High in Mild, Moderate and Severe NPDR Patients
Severity of Retinopathy
Normal or minimal NPDR
Mild NPDR
Moderate NPDR
Severe NPDR
Non-high-risk PDR
High-risk PDR
Management Recommendations for Patients with Diabetes
Presence of
Macular
Panretinal
Photocoagulation
(Scatter) Laser
Focal and/or
Grid Laser*
Edema
No
No
NCI-DME
CI-DME+
No
NCI-DME
CI-DME+
No
NCI-DME
CI-DME+
No
NCI-DME
CI-DME+
No
NCI-DME
CI-DME+
Follow-up
(Months)
12
12
3-6
1*
6-12+
3-6
1*
3-4
2-4
7
1*
3-4
2-4
1*
2-4
2-4
1*
No
No
No
No
No
No
No
Sometimes
Sometimes
Sometimes
Sometimes
Sometimes
Sometimes
Recommended
Recommended
Recommended
No
No
Sometimes
Rarely
No
Sometimes
Rarely
No
Sometimes
Rarely
No
Sometimes
Sometimes
No
Sometimes
Sometimes
Intravitreal Anti-
VEGF Therapy
No
No
No
Usually
No
Rarely
Usually
Sometimes
Sometimes
Usually
Sometimes
Sometimes
Usually
Sometimes ¹,2
Sometimes
Usually
Ocuphire Source: Diabetic Retinopathy Preferred Practice Pattern - AAO 2019; LTFU: Lost To Follow-up; IVT: Intravitreal Injections; PRP: Panretinal Photocoagulation
PHARMA
An oral option
for DR strengthens
treatment options
across all stages
Physicians
have limited
non-invasive
treatment options
23View entire presentation